US Stock MarketDetailed Quotes

ABBV AbbVie

Watchlist
  • 205.290
  • +2.570+1.27%
Close Mar 28 16:00 ET
  • 204.000
  • -1.290-0.63%
Post 20:01 ET
362.41BMarket Cap85.90P/E (TTM)

AbbVie Key Stats

AbbVie Q4 2024 Earnings Date

Currency:USDJan 31, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
14.83B
15.10B
+275.14M
Beat Est.
+3.68%
+5.60%
+1.86%
EPS
-0.49
-0.02
+0.47
Beat Est.
-207.59%
-104.35%
+95.96%
Strong Buy

Mar 29, 2025

AbbVie Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 14.716B--
--2025/Q1-- / 12.914B--
Jan 31, 20252024/Q415.102B / 14.827B--
Oct 30, 20242024/Q314.460B / 14.277B--
Jul 25, 20242024/Q214.462B / 14.027B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 14.716B--
--2025/Q1-- / 12.914B--
Jan 31, 20252024/Q415.102B / 14.827B--
Oct 30, 20242024/Q314.460B / 14.277B--
Jul 25, 20242024/Q214.462B / 14.027B--

Unlock Free Earnings Estimates

AbbVie Earnings Reports

Read more

Market Insights

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More